Dallinga-Thie GM - Search Results

1

Plasma phospholipid transfer protein activity is decreased in type 2 diabetes during treatment with atorvastatin: a role for apolipoprotein E?

Dallinga-Thie GM, van Tol A, Hattori H, Rensen PC, Sijbrands EJ. Dallinga-Thie GM, et al. Diabetes. 2006 May;55(5):1491-6. doi: 10.2337/db05-1685. Diabetes. 2006. PMID: 16644710 Free article. Clinical Trial.

2

Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes.

van Venrooij FV, Stolk RP, Banga JD, Sijmonsma TP, van Tol A, Erkelens DW, Dallinga-Thie GM; DALI Study Group. van Venrooij FV, et al. Diabetes Care. 2003 Apr;26(4):1216-23. doi: 10.2337/diacare.26.4.1216. Diabetes Care. 2003. PMID: 12663600 Clinical Trial.

3

Concerted actions of cholesteryl ester transfer protein and phospholipid transfer protein in type 2 diabetes: effects of apolipoproteins.

Dallinga-Thie GM, Dullaart RP, van Tol A. Dallinga-Thie GM, et al. Curr Opin Lipidol. 2007 Jun;18(3):251-7. doi: 10.1097/MOL.0b013e3280e12685. Curr Opin Lipidol. 2007. PMID: 17495597 Review.

4

Derangements of intravascular remodeling of lipoproteins in type 2 diabetes mellitus: consequences for atherosclerosis development.

Dallinga-Thie GM, Dullaart RP, van Tol A. Dallinga-Thie GM, et al. Curr Diab Rep. 2008 Feb;8(1):65-70. doi: 10.1007/s11892-008-0012-3. Curr Diab Rep. 2008. PMID: 18367001 Review.

5

Plasma apolipoprotein A5 and triglycerides in type 2 diabetes.

Dallinga-Thie GM, van Tol A, Hattori H, van Vark-van der Zee LC, Jansen H, Sijbrands EJ; DALI study group. Dallinga-Thie GM, et al. Diabetologia. 2006 Jul;49(7):1505-11. doi: 10.1007/s00125-006-0261-0. Epub 2006 Apr 28. Diabetologia. 2006. PMID: 16752169 Clinical Trial.

6

Role of plasma adiponectin on the HDL-cholesterol raising effect of atorvastatin in patients with type 2 diabetes.

van Hoek M, van Tol A, van Vark-van der Zee LC, Jansen H, Kastelein JJ, Sijbrands EJ, Dallinga-Thie GM. van Hoek M, et al. Curr Med Res Opin. 2009 Jan;25(1):93-101. doi: 10.1185/03007990802596813. Curr Med Res Opin. 2009. PMID: 19210142 Clinical Trial.

7

Plasma pre beta-HDL formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: Role of phospholipid transfer protein.

Dallinga-Thie GM, van Tol A, Dullaart RP; Diabetes Atorvastatin lipid intervention (DALI) study group. Dallinga-Thie GM, et al. Biochim Biophys Acta. 2009 Aug;1791(8):714-8. doi: 10.1016/j.bbalip.2009.03.008. Epub 2009 Mar 19. Biochim Biophys Acta. 2009. PMID: 19303940 Clinical Trial.

8

Acute elevation of plasma PLTP activity strongly increases pre-existing atherosclerosis.

Moerland M, Samyn H, van Gent T, van Haperen R, Dallinga-Thie G, Grosveld F, van Tol A, de Crom R. Moerland M, et al. Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1277-82. doi: 10.1161/ATVBAHA.108.165084. Epub 2008 Apr 17. Arterioscler Thromb Vasc Biol. 2008. PMID: 18421000

9

Statin and fibrate combination does not additionally lower plasma cholesteryl ester transfer in type 2 diabetes mellitus.

de Vries R, Dikkeschei BD, Sluiter WJ, Dallinga-Thie GM, van Tol A, Dullaart RP. de Vries R, et al. Clin Lab. 2012;58(11-12):1231-9. Clin Lab. 2012. PMID: 23289194 Clinical Trial.

10

Novel roles of hepatic lipase and phospholipid transfer protein in VLDL as well as HDL metabolism.

van Haperen R, Samyn H, van Gent T, Zonneveld AJ, Moerland M, Grosveld F, Jansen H, Dallinga-Thie GM, van Tol A, de Crom R. van Haperen R, et al. Biochim Biophys Acta. 2009 Oct;1791(10):1031-6. doi: 10.1016/j.bbalip.2009.06.001. Epub 2009 Jun 11. Biochim Biophys Acta. 2009. PMID: 19524061

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters